KMI
67
-2
MET
72
5
MSFT
50
3
VTR
47
-7
PSX
47
2
CFG
70
6
PRGO
39
3
SCHW
62
-2
URBN
56
14
RL
72
4
NVDA
56
-4
TRIP
47
3
INTU
56
-4
TGT
22
2
NDAQ
62
2
LYB
39
2
STZ
54
-3
GT
62
6
JPM
69
2
CF
57
-2
KMI
67
-2
MET
72
5
MSFT
50
3
VTR
47
-7
PSX
47
2
CFG
70
6
PRGO
39
3
SCHW
62
-2
URBN
56
14
RL
72
4
NVDA
56
-4
TRIP
47
3
INTU
56
-4
TGT
22
2
NDAQ
62
2
LYB
39
2
STZ
54
-3
GT
62
6
JPM
69
2
CF
57
-2
Financhill
Back

NeueHealth 10K Form

Sell
32

NEUE
NeueHealth

Last Price:
4.82
Seasonality Move:
-5.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NEUE News And Ratings

See the #1 stock for the next 7 days that we like better than NEUE

NEUE Financial Statistics

Sales & Book Value

Annual Sales: $1.16B
Cash Flow: $-22.34M
Price / Cash Flow: 0
Annual Sales: $-163.05
Price / Book: 0

Profitability

EPS (TTM): -51.16000
Net Income (TTM): $-361.67M
Gross Margin: $164.22M
Return on Equity: 0%
Return on Assets: -30.24%

NeueHealth Earnings Forecast

Key NeueHealth Financial Ratios

  • The Gross Profit Margin over the past 6 years for NEUE is 14.15%.
  • The Selling, General & Administrative Expenses for NEUE have been equal to 22.33% of Gross Profit Margin.
  • The Research & Development expenses have been 1.95% of Revenue.
  • The Interest Expense is -3.32% of Operating Income.
  • The Net Earning history of NEUE is -99.19% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

NeueHealth Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: NEUE
Website: neuehealth.com

Debt

Debt-to-Equity Ratio: -0.28
Current Ratio: 0.68
Quick Ratio: 0.48

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NEUE Technical Analysis vs Fundamental Analysis

Sell
32
NeueHealth (NEUE) is a Sell

Is NeueHealth a Buy or a Sell?

  • NeueHealth stock is rated a Sell
    The current NeueHealth [NEUE] share price is $5.00. The Score for NEUE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.